Clinical Trial Update: A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 follow-up study assessing anti-human growth hormone antibodies after Zomacton in children with idiopathic growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Growth Hormone Deficiency

Drugs mentioned

• ZOMACTON (Somatropin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Idiopathic Growth Hormone Deficiency | Phase 3 | Status: COMPLETED